The Anti-Aging Supplements Market is expected to reach $5.45 billion in 2030 at a CAGR of 7.7%, driven by preventive healthcare adoption
Read More
The Anti-Aging Drugs Market is expected to reach $91.23 billion in 2030 at a CAGR of 8.6%, driven by personalized medicine demand
Read More
The Anti-Aging Market is expected to reach $92.58 billion in 2030 at a CAGR of 8.1%, driven by non-surgical treatments
Read More
The Anti Microbial Peptides Market is expected to reach $10.4 billion in 2030 at a CAGR of 8.1%, driven by AMP-based therapeutics commercialization
Read More
The Anthrax Vaccine Market is expected to reach $14.49 billion in 2030 at a CAGR of 4.1%, driven by biodefense programs
Read More
The anthracycline market is projected to reach $2.25 billion by 2030 at a 7.4% CAGR, driven by liposomal formulations, combination therapies, and generic chemotherapy adoption.
Read More
The anthelmintic drugs market is projected to reach $4.32 billion by 2030 at a 5.2% CAGR, driven by novel compounds, combination therapies, and veterinary & livestock use.
Read More
The antacids market is projected to reach $11.57 billion by 2030 at a 3.3% CAGR, driven by natural/herbal formulations, personalized medicine, and e-pharmacy growth.
Read More
The animal model market is projected to reach $2.97 billion by 2030 at a 7.3% CAGR, driven by AI adoption, precision medicine, genetically engineered models, and CRO expansion.
Read More
The angiotensin receptor blockers (ARBs) market is projected to reach $11.02 billion by 2030 at a 4.7% CAGR, driven by personalized hypertension care, CKD treatments, and advanced drug delivery.
Read More